Drug intelligence / Profile preview

Universal Serum

Development stage
Unknown
Lead developer
Bioveta
Modality
Antibody-Based Therapeutics
Administration
Intramuscular, Subcutaneous, Intravenous
01

Overview

"Universal Serum" is a non-specific name that refers to several distinct pharmaceutical and biological products. Most commonly, it refers to **Universal Serum (Bioveta)**, a veterinary heterologous hyperimmune serum derived from horses. This product contains a polyvalent mixture of immunoglobulins (antibodies) targeting common pathogens in livestock, such as *Pasteurella multocida*, *Escherichia coli*, *Arcanobacterium pyogenes*, and *Fusobacterium necrophorum*, and is used for passive immunization and the treatment of respiratory and gastrointestinal infections in cattle, horses, sheep, and pigs. In human medicine, the term is often used colloquially to describe **Universal Antivenom** (e.g., the polyvalent antivenoms produced by the Pasteur Institute), which are designed to neutralize the venoms of multiple snake species. Historically, "Universal Serum" (Sérum Universel) also referred to **Quinton Marine Serum**, an isotonic seawater solution used for rehydration and mineral therapy. In laboratory settings, **Human AB Serum** is sometimes called "universal serum" because it lacks anti-A and anti-B antibodies, making it a versatile reagent for cell culture and a neutral plasma product for recipients of any blood type.

Brand names
Universal Serum
Other names
Sérum universaleBioveta Universal SerumSérum Universel

Beyond the preview

Go deeper on Universal Serum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Universal Serum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call